RxDoctor Payments Data

Rajesh Kakarla, MD

Vascular & Interventional Radiology · Rockford, ILNPI 1609026467

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (55.2%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Penumbra, Inc. accounts for 78.3% of it on its own, with 29 other manufacturers making up the rest. Among vascular & interventional radiology clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$99,431in general payments, 2019–2025

Across 307 payments — averaging $323.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Penumbra, Inc.$78K
  • Inari Medical, Inc.$5K
  • Abbott$4K
  • Philips North America LLC$2K
  • W. L. Gore & Associates, Inc.$2K
  • Stryker$1K
  • plus $6K from 24 others
$19,600in research payments, 2019–2025

Across 5 payments — averaging $3920.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Inari Medical, Inc.$20K

What the payments were for

  • Consulting fees$4130%
  • Speaking & faculty fees$54,92555%
  • Travel & lodging$27,82328%
  • Food & beverage$16,05516%
  • Education$2150%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$99,431 in reported general payments places this provider in the 90th percentile of 197 vascular & interventional radiology providers in Illinois.

See all vascular & interventional radiology providers in Illinois

Medicare billing

Part B allowed, 2024
$201,347
Medicare patients
1,894
Services billed
4,600

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate45$608

Paid to pharmacies, not to this prescriber.

Other vascular & interventional radiology in Rockford

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →